NCT00132873View on ClinicalTrials.gov

Trial of Xyrem® (Sodium Oxybate) for the Treatment of Narcolepsy

PHASE3CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

September 30, 2007

Study Completion Date

December 31, 2007

Conditions
Narcolepsy
Interventions
DRUG

Xyrem (sodium oxybate) oral solution

Xyrem (sodium oxybate) oral solution

Trial Locations (1)

M8X 2W2

Brain and Sleep Diagnostic Centre, Toronto

Sponsors
All Listed Sponsors
lead

Jazz Pharmaceuticals

INDUSTRY